These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14631582)

  • 1. [End-organ damage in inflammation and sepsis].
    Müller-Werdan U; Werdan K
    Internist (Berl); 2003 Jul; 44(7):864-71. PubMed ID: 14631582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
    Hotchkiss RS; Monneret G; Payen D
    Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system: relation to sepsis and multiple organ failure.
    Kellum JA; Decker JM
    AACN Clin Issues; 1996 Aug; 7(3):339-50; quiz 459-60. PubMed ID: 8826396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against RAGE in sepsis and inflammation: implications for therapy.
    Lutterloh EC; Opal SM
    Expert Opin Pharmacother; 2007 Jun; 8(9):1193-6. PubMed ID: 17563255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Critical Care for the Patient with Sepsis and Multiple Organ Dysfunction.
    Kaml GJ; Davis KA
    Anesthesiol Clin; 2016 Dec; 34(4):681-696. PubMed ID: 27816128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis.
    Perl M; Chung CS; Garber M; Huang X; Ayala A
    Front Biosci; 2006 Jan; 11():272-99. PubMed ID: 16146731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis: the need for tolerance not complacency.
    Velho TR; Santos I; Póvoa P; Moita LF
    Swiss Med Wkly; 2016; 146():w14276. PubMed ID: 26900874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical management of patients with sepsis].
    Weigand MA; Bardenheuer HJ; Böttiger BW
    Anaesthesist; 2003 Jan; 52(1):3-22. PubMed ID: 12577161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cell activation in sepsis.
    Bellingan G
    Br Med Bull; 1999; 55(1):12-29. PubMed ID: 10695077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral 5-HT7 receptors as a new target for prevention of lung injury and mortality in septic rats.
    Cadirci E; Halici Z; Bayir Y; Albayrak A; Karakus E; Polat B; Unal D; Atamanalp SS; Aksak S; Gundogdu C
    Immunobiology; 2013 Oct; 218(10):1271-83. PubMed ID: 23694713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagal Modulation of the Inflammatory Response in Sepsis.
    Wang DW; Yin YM; Yao YM
    Int Rev Immunol; 2016 Sep; 35(5):415-433. PubMed ID: 27128144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating the inflammatory response in sepsis.
    Leitman IM
    J Surg Res; 2011 Dec; 171(2):e183-5. PubMed ID: 21962808
    [No Abstract]   [Full Text] [Related]  

  • 16. Is neuroimmunomodulation a future therapeutic approach for sepsis?
    Kumar V; Sharma A
    Int Immunopharmacol; 2010 Jan; 10(1):9-17. PubMed ID: 19840870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.
    Schulte W; Bernhagen J; Bucala R
    Mediators Inflamm; 2013; 2013():165974. PubMed ID: 23853427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory therapies in sepsis.
    Kox WJ; Volk T; Kox SN; Volk HD
    Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in soluble protein oligomers triggers the innate immune system promoting inflammation and vascular dysfunction in the pathogenesis of sepsis.
    Komic A; Martinez-Quinones P; McCarthy CG; Webb RC; Wenceslau CF
    Clin Sci (Lond); 2018 Jul; 132(13):1433-1438. PubMed ID: 30021912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.